EX-99.2 3 axmexhibit99two.htm ACQUISITION RESTRUCTURE AND TECHNOLOGY TRANSFER AGREEMENT, DATED JANUARY 7, 2007 AXM Pharma, Inc. Exhibit 99.2  1/16/2007

Acquisition Restructure & Technology Transfer Agreement


Party A:  AXM Pharma (Shenyang), Inc.

Party B:  Beijing Yuhuatang Biological Sci-Tech Development Co., Ltd

On the basis of complementing advantages for each other, mutual
benefit and mutual development, Party A and Party B, through friendly
negotiation, reached the following agreement on acquisition restructure
and technology transfer:

1.

Both parties confirm that the entire fixed assets and technology value

 

of Party B is worth RMB 45,000,000 (the actual assessed value is RMB

 

59,830,000).

  

2.

Party A will furnish 4,500,000 shares of its Parent company-AXM

 

Pharma (US), Inc. to Party B at the price of $ 1.25 per share by the

 

integral number of which is equivalent to RMB 45,000,000. Therewith,

 

Party B is entitled to own the share rights calculated in US dollars

 

equivalent to RMB 45,000,000 of Party A. Thus, Party B becomes a

 

wholly owned subsidiary of Party A. Meanwhile, Party A will pay

 

RMB 1,000,000 in cash to Party B. Party A will own the State Fund  

 

for Technology Innovation obtained by Party B’s application.

  

3.

After acquired by Party A, legal representative and organization





 

structure of Party B will be defined by the board of directors. Party B is

 

entitled to arrange for their operation and business according to

 

circumstances.

  

4.

Party B will transfer all their access of technology to Party A, including

 

AD, ADD, Testosterone, Testosterone undecanoate, Adriamycin,

 

Lovastatin,Phytosrterol, Daptomycin, Geldanamycin (the last two is

 

under development now), as well as Xin-nao-xin (Chinese

 

Pinyin)whose pre-clinical study has been completed.

  

5.

Party B promises that its access to these technologies will not be

 

transferred to a third party and will take all responsibilities as well as

 

compensate to Party A for its losses thus produced if Party B breaks its

 

promise .

  

6.

Party B should be responsible for all its creditor’s rights and liabilities

 

before this agreement is signed;after that, Party B need not bear any

 

right of their common creditor’s right and liability without permission

 

from Party A.

  

7.

Party A will pay Party B for all its equipment renewal, technical

 

development and research, staff salary, renting fees, as well as all its

 

operation fees. Party B should produce all these financial statements to





 

Party A for each month. Party A should response promptly without

 

disturbing Party B’s regular operation.

  

8.

Party B will infuse to Party A all its current assets, intellectual property,

 

future intellectual property as well as various operational income

  

9.

Party B will transfer the role of general agent of GM1 to Party A and

 

Party B promises that it burdens no liability for GM1.

  

10.

All original documents of foresaid technologies will be transferred to

 

Party A for record and Party B is responsible for taking back all

 

documents and materials that are kept elsewhere.

  

11.

This agreement is made in three copies and will take effect after it’s

 

signed. Party A and Party B shall negotiate any unforeseeable issues

 

friendly and cooperatively.



Party A:


January 7th, 2007

Party B: